Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation

Circulation Journal : Official Journal of the Japanese Circulation Society
Akira FujikiHiroshi Inoue

Abstract

The aim of this study was to evaluate pharmacological cardioversion of long-lasting persistent atrial fibrillation (AF) using bepridil in terms of recovery of atrial mechanical function and maintenance of sinus rhythm. Bepridil alone or in combination with aprindine is effective for termination of persistent AF. The study group comprised 38 consecutive patients (24 men, 58.8+/-9.3 years) with successful conversion of persistent AF lasting >1 month either pharmacologically (Group I) or electrically (Group II). Fast Fourier transform analysis of fibrillation waves was performed and fibrillation cycle length (FCL) was calculated from the peak frequency. In Group I, sinus rhythm was pharmacologically restored in 22 patients after an average 30 days (7-49 days) of bepridil administration, either alone (11) or in combination with oral aprindine (11); they were followed up while using the same drugs. In Group II, electrical conversion restored sinus rhythm in 16 patients, and they were followed up with conventional antiarrhythmic drugs other than bepridil and aprindine. After bepridil treatment FCL increased and became significantly longer in Group I than in Group II (190+/-39 vs 150+/-29 ms, p<0.001). Atrial peak velocity in transmit...Continue Reading

References

Jun 1, 1994·Journal of the American College of Cardiology·W J ManningP S Douglas
May 15, 1998·Journal of the American College of Cardiology·R H FalkV Abascal
Nov 17, 2001·European Journal of Pharmacology·S KobayashiH Nakaya
Nov 7, 2002·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuhiro YoshigaMasunori Matsuzaki
Dec 6, 2002·The New England Journal of Medicine·Isabelle C Van GelderUNKNOWN Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group
Jan 28, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinichi NiwanoTohru Izumi
May 9, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Akira FujikiHiroshi Inoue
Aug 14, 2003·The American Journal of Cardiology·Akira FujikiHiroshi Inoue
Aug 27, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi YamashitaUNKNOWN J-RHYTHM Investigators

❮ Previous
Next ❯

Citations

May 14, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Shinichi NiwanoTohru Izumi
Jan 6, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Masataka WatanabeAkira Yamashina
Oct 3, 2012·European Journal of Pharmacology·Sayuri SuzukiIchiro Hisatome
Nov 17, 2009·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Shinsuke MiyazakiAtsushi Takahashi
Dec 24, 2005·Cell Motility and the Cytoskeleton·Zoltán KrasznaiTeréz Márián
May 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Kaoru OkishigeUNKNOWN Pilsicainide Suppression Trial for Persistent Atrial Fibrillation II Investigators
Jul 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Takayuki TsunedaHiroshi Inoue
Dec 6, 2007·Circulation Journal : Official Journal of the Japanese Circulation Society·Akira Fujiki, Hiroshi Inoue
Nov 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Yasuo OkumuraKatsuo Kanmatsuse
Jan 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Daisuke SatoTohru Izumi
Jan 26, 2006·Circulation Journal : Official Journal of the Japanese Circulation Society·Takeshi SasakiTohru Izumi
Aug 24, 2012·Journal of Cardiovascular Medicine·Atsushi ShamotoKenji Sunagawa
Jul 18, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Toshiyuki OsakaItsuo Kodama
Mar 16, 2006·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Akira Fujiki
May 25, 2021·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Bahij KreidiehPeter R Kowey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Related Papers

Circulation Journal : Official Journal of the Japanese Circulation Society
Yuji NakazatoHiroyuki Daida
Circulation Journal : Official Journal of the Japanese Circulation Society
Masayuki YasudaHiroyuki Daida
© 2021 Meta ULC. All rights reserved